The floor price for the transaction has been set at ₹1,279.80 per share, representing a likely discount to the prevailing market price, sources in the know told CNBC-TV18. Shares of Emcure Pharmaceuticals Ltd ended at ₹1,281.15, up by ₹9.75, or 0.77%, on the BSE.
